Cellworks | Personalized Cancer Therapy

Precision Biosimulation

Improve drug development and patient outcomes

WATCH VIDEO

Poster Presentation at Annual SNO Meeting
Cellworks Therapy Biosimulation Study Reveals
Promising New Biomarkers for TMZ Resistance
In Glioblastoma Patients
Read Press Release

Precise

PHYSICIAN

Extend lives with cancer treatment predictors

Read More

Personalized cancer treatments for your patients

PATIENT

Precise treatment today for a better tomorrow

Read More

PAYOR

Effective intervention for better patient outcomes; prolongs lives and saves costs

Read More

Insured support for cancer treatment

BIOPHARMA

Extend lives with cancer treatment predictors

Read More

Drug development through software cell modeling

Precision by Biosimulation

BIOSIMULATION
PLATFORM

PRECISION MEDICINE PRODUCTS

FEATURED CONTENT

FEATURED ARTICLE

Cellworks Singula™ TRI predicts clinical outcomes for esophageal adenocarcinoma: myCare-004

FEATURED PUBLICATION

Cellworks Study identifies biomarkers for TMZ resistance in m-MGMT GBM patients

FEATURED VIDEO

View how personalized therapy biosimulation works

FEATURED BLOG

Moving Oncology Beyond ‘One Mutation, One Drug’

NEWS

Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ…

Personalized Therapy Biosimulation Identifies m-MGMT GBM Patients Who Will Develop Early Progress…

Cellworks Wins Dell Technologies The Challengers 2022 Innovative Business of…

Leading Genomic Biosimulation Company Recognized for its High Performance Computing (HPC) Cloud I…

COLLABORATORS

OUR PARTNERS IN REVOLUTIONIZING CANCER TREATMENT.

Top